ATE251162T1 - Triazolo(4,5-d)pyrimidin-verbindungen - Google Patents

Triazolo(4,5-d)pyrimidin-verbindungen

Info

Publication number
ATE251162T1
ATE251162T1 AT99941925T AT99941925T ATE251162T1 AT E251162 T1 ATE251162 T1 AT E251162T1 AT 99941925 T AT99941925 T AT 99941925T AT 99941925 T AT99941925 T AT 99941925T AT E251162 T1 ATE251162 T1 AT E251162T1
Authority
AT
Austria
Prior art keywords
triazolo
pyrimidine compounds
pyrimidine
compounds
medicaments
Prior art date
Application number
AT99941925T
Other languages
English (en)
Inventor
Simon Guile
Brian Springthorpe
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE251162T1 publication Critical patent/ATE251162T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99941925T 1998-07-17 1999-07-15 Triazolo(4,5-d)pyrimidin-verbindungen ATE251162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802574A SE9802574D0 (sv) 1998-07-17 1998-07-17 Novel compounds
PCT/SE1999/001277 WO2000004021A1 (en) 1998-07-17 1999-07-15 NOVEL TRIAZOLO[4,5-d]PYRIMIDINE COMPOUNDS

Publications (1)

Publication Number Publication Date
ATE251162T1 true ATE251162T1 (de) 2003-10-15

Family

ID=20412117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941925T ATE251162T1 (de) 1998-07-17 1999-07-15 Triazolo(4,5-d)pyrimidin-verbindungen

Country Status (7)

Country Link
EP (1) EP1097153B1 (de)
JP (1) JP2003519080A (de)
AT (1) ATE251162T1 (de)
AU (1) AU5539899A (de)
DE (1) DE69911785T2 (de)
SE (1) SE9802574D0 (de)
WO (1) WO2000004021A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
EP1685135B1 (de) 2003-10-21 2010-05-26 Inspire Pharmaceuticals, Inc. Tetrahydrofuro[3,4-d]dioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
JP2007509180A (ja) 2003-10-21 2007-04-12 インスパイアー ファーマシューティカルズ，インコーポレイティド 疼痛を治療するための、非ヌクレオチド組成物および方法
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JP2010508350A (ja) 2006-10-31 2010-03-18 ヤンセン ファーマシューティカ エヌ．ベー． Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体
WO2015162630A1 (en) * 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
CR20180452A (es) 2016-03-22 2019-02-06 Merck Sharp & Dohme Moduladores alostéricos de receptores de acetilcolina nicotícos
CN111116592A (zh) * 2019-11-27 2020-05-08 杭州沧海帆医药科技有限公司 嘧啶并三氮唑类化合物及其医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL182680B1 (pl) * 1995-07-11 2002-02-28 Astrazeneca Ab Nowe inhibitory skupiania się płytek krwi
CA2241687A1 (en) * 1996-10-30 1998-05-07 Kenneth A. Jacobson P2y receptor antagonists
AU5501598A (en) * 1996-12-20 1998-07-17 Astra Pharmaceuticals Limited Triazolo{4,5-(d)}pyrimidinyl derivatives and their use as medicaments
SE9702772D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
DE69911785T2 (de) 2004-07-29
AU5539899A (en) 2000-02-07
DE69911785D1 (de) 2003-11-06
JP2003519080A (ja) 2003-06-17
EP1097153A1 (de) 2001-05-09
EP1097153B1 (de) 2003-10-01
WO2000004021A1 (en) 2000-01-27
SE9802574D0 (sv) 1998-07-17

Similar Documents

Publication Publication Date Title
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
TR200000151T2 (tr) Yeni bileşimler.
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
PT1289992E (pt) Nova forma cristalina de um composto de triazolo (4,5-d) pirimidina
AU2003228770A8 (en) Substituted pyrazolopyrimidines
AU2002239344A1 (en) Pyrazolopyridines
CA2338600A1 (en) Novel thiazolopyrimidine compounds
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
TR200000152T2 (tr) Yeni bileşikler.
SE9904129D0 (sv) Novel compounds
AU2003217712A1 (en) Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
SE9804212D0 (sv) Compounds
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
DE60201074D1 (en) Pyrazolopyridinderivate
SE9904128D0 (sv) Novel compounds
SE0004099D0 (sv) Novel compounds
SE0004098D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties